In transcriptomic cohorts, high expression of CCNB1 was associated with worse outcomes which was also obvious at the protein level independent on other prognostic factors, including LVI status, tumour size, LN stage and tumour grade. This evidence concerns the gene CCNB1 and neoplasm.